InvestorsHub Logo
Followers 20
Posts 5327
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Thursday, 07/18/2013 9:26:55 PM

Thursday, July 18, 2013 9:26:55 PM

Post# of 26138
The only partners listed on ANI website are Teva and Aduro.

Begs to question what about Elestrin and Meda agreeement.

In fairness Pryzbyl has stated in the past he brings to light immediate revenue generators only, focusing in the present Elestrin milestone payments may be too far off for him to include in the filing.

On the other hand you have to wonder, is the women's division being sold?

From the Exhibit 99.1

ANI is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. In two facilities with combined manufacturing, packaging and laboratory capacity totaling 173,000 square feet, ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies. Over the last two years ANI has launched three new products and has eleven products in development. ANI’s targeted areas of product development include narcotics, anti-cancers and hormones (potent compounds), and extended release niche generic product opportunities. ANI’s other products include an FDA-approved testosterone gel, which is licensed to Teva Pharmaceuticals USA. For more information please visit our website www.anipharmaceuticals.com.



They know we have been watching and researching their moves and continue to do so. This will persist until the trust in the new management has been reestablished (still a long way to go). In the meantime I continue to build a case I hope, we will never have to use.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.